Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company's shares could potentially skyrocket in value.
Get all the details on this potential penny stock

LXRP Insider Trading (Lexaria Bioscience)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $39,100.00
Insider Selling (Last 12 Months): $0.00

Lexaria Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at Lexaria Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lexaria Bioscience Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 01/11/2021 01:00 AM ET

This chart shows the closing price history over time for LXRP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
pixel

Lexaria Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2020Christopher BunkaCEOBuy195,500$0.20$39,100.00
See Full Table
Insider Trading at Lexaria Bioscience?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Lexaria Bioscience and related companies.

SEC Filings (Institutional Ownership Changes) for Lexaria Bioscience (OTCMKTS:LXRP)

0.11% of Lexaria Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.
Read More on Lexaria Bioscience

Today's Range

Now: N/A

50 Day Range

MA: $0.23
Low: $0.22
High: $0.28

52 Week Range

Now: N/A

Volume

2,151,500 shs

Average Volume

608,350 shs

Market Capitalization

$20.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Lexaria Bioscience?

Lexaria Bioscience's top insider investors include:
  1. Christopher Bunka (CEO)
Small Cap Wonder
Read why this microcap stock might stand out in the market.
Get the info now.